Ozempic alternatives include other GLP-1 medications, non-GLP-1 weight loss options, and complementary peptide approaches that may provide benefits at lower price points
Glycine steps in to help trigger GLP-1 release by working with your intestinal cells
Sleep issues and depression seem to go hand in hand, with both insomnia and hypersomnia (sleeping too much) being common complaints of people with depression
Structural Basis for GLP-1 Receptor Activation by LY3502970, an Orally Active Nonpeptide Agonist
Correcting any genuine deficiency as part of a holistic health review is sensible, but this should be seen as supporting overall wellbeing rather than as a weight loss strategy in itself
Lilly reported producing more than 1.6 times the salable incretin doses in the first half of 2025 compared to the same period in 2024, with plans for significant additional manufacturing expansion [39]